Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

COVID-19 can cause various skin problems, including reactions to protective gear and medication, with different rates reported worldwide, and more research is needed to fully understand these skin issues.

Off-label drug use can be risky but sometimes beneficial when standard treatments fail.

Some skin conditions look like acne but are caused by drugs, and they usually get better when the drug is stopped.

Lipid nanoparticles improve drug delivery through the skin, offering stability, controlled release, and better compatibility with skin.

Recognizing and treating related skin conditions can improve atopic dermatitis management.

About 22% of cancer patients had skin-related side effects from chemotherapy, but these were usually not severe enough to halt treatment.

Nanoparticulate systems improve drug delivery by controlling release, protecting drugs, changing absorption and distribution, and concentrating drugs in targeted areas.

Optimized emulgels with Levofloxacin effectively treat eye infections with prolonged drug release and safety.

Certain hormone treatments can improve acne and related conditions in women.

The model and estimator can predict drug exposure in kidney transplant patients well.

Avoiding dyed wigs and clothing improved severe allergic reactions in a woman treated with diphencyprone.

Accurate diagnosis is crucial for effectively treating severe alopecia and related symptoms.

Interferon beta treatment in MS patients can cause skin reactions and increased hair loss.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Ingenol mebutate gel changes gene expression related to skin development and immune response in actinic keratosis.

Topical finasteride with EGCG or TA improves drug release and dermal uptake, potentially treating hair loss effectively.

A new hair loss treatment uses tiny needles to deliver a drug-loaded lipid carrier, promoting hair growth more effectively than current treatments.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

A toddler who accidentally swallowed hair growth medicine experienced serious heart-related side effects but recovered after hospital treatment.

Docetaxel, a chemotherapy drug, was reported to cause psoriasis in a patient for the first time.

The EFSUMB created basic guidelines for using ultrasound in skin-related medical practice.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

Hair loss in Rhesus macaques may be caused by a skin allergy-related condition.

Scientists created tiny particles loaded with a hair growth drug, minoxidil, that specifically target hair follicles and skin cells to potentially improve hair growth.

Gut bacteria affect female reproductive health and may help diagnose and treat related diseases.

Glycopeptide hydrogels are promising for tissue repair, drug delivery, and healing due to their multifunctional properties.

The document concludes that early diagnosis of Balint's syndrome is crucial for effective treatment and that understanding drug interactions, like between ritonavir and statins, is important for patient care.

Skin enzymes convert topical drugs into active forms, affecting drug effectiveness and safety.

Sertraline can cause hair loss, which stops after stopping the drug.